ApoRx Biopharmaceuticals
Targeted Protein Degradation Drug Discovery
StartupApoRx Biopharmaceuticals is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2021. Targeted Protein Degradation Drug Discovery. ApoRx Biopharmaceuticals was founded by Avishai Levy, Omri Erez, Philippe Nakache, Orna Harel. The company has 1-10 employees. Core technologies: Biologicals, Cells.
The company follows a B2B business model. Product stage: R&D.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQNess Ziona
- DistrictCenter District
- Last RoundUndisclosed
Avishai LevyCo-founder & CEO
Omri ErezFounder
Philippe NakacheCo-founderOrna HarelCo-founder
What does ApoRx Biopharmaceuticals do?
ApoRx is a drug-discovery company focusing on the discovery, design, characterization, and development of small proteolysis-targeting molecules against well-validated disease-causing proteins in cancer and other indications. The core of its technology is the Aperion library, a proprietary focus library of RING E3 ligase binders that is designed to harness the intracellular ubiquitin-proteasome machinery to degrade and destroy unwanted proteins via targeted protein degradation. ApoRx is a subsidiary of Agbiopro Protein Degradation Hub, a management and consulting firm.
Who founded ApoRx Biopharmaceuticals?
ApoRx Biopharmaceuticals was founded in 2021 by Avishai Levy (Co-founder & CEO), Omri Erez (Founder), Philippe Nakache (Co-founder), Orna Harel (Co-founder ).
What sector is ApoRx Biopharmaceuticals in?
ApoRx Biopharmaceuticals operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is ApoRx Biopharmaceuticals located?
ApoRx Biopharmaceuticals is based in Ness Ziona, Israel, Center District.